Ignite Creation Date:
2025-12-24 @ 4:19 PM
Ignite Modification Date:
2026-01-07 @ 3:44 AM
Study NCT ID:
NCT06850766
Status:
RECRUITING
Last Update Posted:
2025-11-28
First Post:
2025-02-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Feasibility and Efficacy of Dose Timing (Morning vs Evening) of Temozolomide in the Treatment of Glioblastoma
Sponsor:
Ottawa Hospital Research Institute
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
TMZ-CHRONO
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |